Profil
Ingmar Hoerr was the founder of CureVac NV, where he served as the Chief Executive Officer & Member-Supervisory Board from 2000 to 2020.
Dr. Hoerr is also the founder of CureVac SE.
Dr. Hoerr obtained a doctorate degree from Eberhard Karls Universität Tübingen and an MBA from Donau-Universität Krems.
Aktive Positionen von Ingmar Hoerr
| Unternehmen | Position | Beginn |
|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Gründer | 11.05.2010 |
Ehemalige bekannte Positionen von Ingmar Hoerr
| Unternehmen | Position | Ende |
|---|---|---|
| CUREVAC N.V. | Gründer | 01.03.2020 |
Ausbildung von Ingmar Hoerr
| Donau-Universität Krems | Masters Business Admin |
| Eberhard Karls Universität Tübingen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CUREVAC N.V. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
